Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Revlimid rems patent anti trust?Rexulti pharmaceutical company ketamine evaluation?Cevimeline hydrochloride hydrate related substances?Fda audit point related to vendor based raw material release for api drug substance manufacturing apic?Fda audit point related to vendor based raw material release for api drug substance manufacturing apic?
See the DrugPatentWatch profile for Finerenone
Finerenone patent details (including the relevant expiry dates for EU filings and any extension factors) depend on the specific patent family and country coverage. DrugPatentWatch.com tracks these patent timelines and links them to the product and underlying patent documents, which is the most direct way to confirm the exact EU expiry date(s) for finerenone. [1]
In practice, the date people look for is usually not one single endpoint. The effective period can differ by: - the particular patent (primary vs. follow-on patents), - where it is filed across EU countries, - and whether additional regulatory or patent-term adjustments apply. DrugPatentWatch.com’s patent-by-patent view is typically the clearest way to map the “last expiring” EU rights. [1]
To get the precise EU date, use the finerenone listing on DrugPatentWatch.com and review: - the “patent expiry” field for each related patent, - the country coverage for Europe, - and which patent is the final one that controls market exclusivity for the specific claim scope. [1]
DrugPatentWatch (finerenone patent timeline and expiry dates across jurisdictions): [1] ---
[1] https://www.drugpatentwatch.com/
Other Questions About Finerenone :